<DOC>
	<DOCNO>NCT01750827</DOCNO>
	<brief_summary>This open-label , single dose , single period study . Approximately 14 subject receive one dose 250 mg non-enteric coat SB-659032 follow low-fat breakfast . This study evaluate whether SB-659032 effect platelet function determine platelet aggregation test use agonist ADP collagen . Blood sample PK analysis measurement Lp-PLA2 activity also collect</brief_summary>
	<brief_title>A Study Assess Effect SB 659032 Platelet Function</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Healthy male females 18 55 year age , inclusive . Body weight great 50 kg ( 110 pound ) body mass index ( BMI ) 19 30 : BMI = weight kg ( height meter ) 2 Any clinically relevant abnormality identify screen medical assessment , laboratory examination ECG History asthma , anaphylaxis anaphalactoid reaction , severe allergic response History smoking within six month study and/or positive urine cotinine screen History alcohol consumption exceed , average , 7 drinks/week woman 14 drinks/week men ( 1 drink = 5 ounce wine 12 ounce beer 1.5 ounce hard liquor ) within 6 month first dose study medication Positive urine drug alcohol screening Use aspirin , aspirincontaining product , nonsteroidal antiinflammatory agent antiplatelet medication within 14 day prior first dose study medication ( list drug review subject screening provide take home ) Use prescription ( include hormone replacement therapy ) nonprescription drug vitamin within 7 day 5 halflives ( whichever longer ) prior administration study medication . An exception acetaminophen allow dos less equal 2g/day 48 hour prior dose Use dietary/herbal supplement include ( limited ) St. John 's wort , kava , ephedra ( huang ) , gingko biloba , DHEA , yohimbe , saw palmetto , ginseng red yeast rice within 14 day prior treatment study medication Treatment investigational drug within 30 day 5 halflives ( whichever longer ) prior dose Consumption grapefruit grapefruit juice within 7 day prior first dose study medication A history biliary tract disease include history liver disease elevate liver function test know unknown etiology Pregnant nursing female subject . For female subject , positive serum Î²hCG screen Day 1 ; female subject childbearing potential unwillingness agree one method contraception list protocol screen completion followup procedure . Hormonal contraceptive method ( e.g . oral contraceptive pill , implant ) female subject permit . At least one week interval screen first study drug administration observe pregnancy test . For male subject , unwillingness abstain sexual intercourse pregnant lactate woman unwillingness use condom another form contraception ( e.g. , IUD , birth control pills take female partner , diaphragm spermicide ) engage sexual intercourse woman could become pregnant discharge study Donation blood excess 500 mL within 56 day prior dose Full ADP and/or collageninduced aggregation ( great equal 40 % ) three concentration one agonist , assess Day 1 No ADP collageninduced aggregation ( &lt; 40 % ) high concentration either agonist , assess Day 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>platelet function</keyword>
	<keyword>atherosclerosis ,</keyword>
	<keyword>SB-659032</keyword>
</DOC>